Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 1 19Phase NA 15Phase 1/2 13Phase 3 12Phase 4 4Phase 2/3 3Phase EARLY_PHASE1 2

Status

Unknown 5Completed 5Active not recruiting 5Terminated 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 59Lymphoid 48Other hematologic neoplasm 47CNS 47Other solid neoplasm 40Genitourinary 33Breast 31Plasma cell 29Thoracic 19Tumor-Agnostic 17Head & Neck 14Gynecologic 13Dermatologic 12Sarcoma 7Myeloid 6Endocrine 4Classical hematology 4Other 3NET 2Other neoplasm 1

Conditions

Neuroendocrine Tumors 2Pheochromocytoma 1Paraganglioma 1Neuroblastoma 1

Interventions

gallium Ga 68 dotatate 1Magnetic Resonance Spectroscopy 168Ga-FAPI 13-fluorobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recruiting × NET × Clear all
NCT07132645 2025-09-23

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT05069220 2024-03-01

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Recruiting
150 enrolled
CNSEndocrineNET

Neuroblastoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡